Scotland is home to a flourishing life science industry with government supported plans to increase its size to £8bn by 2025. Bioclusters in Edinburgh, Glasgow, Aberdeen and Dundee provide the expertise, facilities and collaboration opportunities required to enable this growth.

Synpromics is featured in the recent Vision Scotland supplement in The Scotsman, discussing innovative companies whose technologies are set to improve lives on a global scale. Synpromics’ technology gives scientists the power to control gene expression, essential in the rapidly developing area of cell and gene medicine. 

Sandra Dick discusses Synpromics’ technology and recent growth in Vision Scotland: Healthy options in a new age of enlightenment.